Thomas J. Schnitzer

Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.

T. Schnitzer, W. Olson, M. Kamin, 1999, Arthritis and rheumatism.

Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: a randomized, controlled trial

T. Schnitzer, W. B. Edwards, J. Barroso, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time

T. Schnitzer, W. B. Edwards, I. Haider, 2018, Osteoporosis International.

Bone Imaging and Fracture Risk after Spinal Cord Injury

T. Schnitzer, W. B. Edwards, Thomas J. Schnitzer, 2015, Current Osteoporosis Reports.

Monthly treatment with romosozumab for 1 year increases bone mineral at the hip, but not the knee, in women with chronic spinal cord injury

Thomas J. Schnitzer, Narina Simonian, Laura E. Crack, 2024, JBMR Plus.

Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations.

P. Conaghan, J. Gewandter, B. Reeve, 2024, Pain.